BlackRock, Inc. 13D and 13G filings for Intercept Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-07 4:35 pm Purchase | 2023-06-30 | 13G | Intercept Pharmaceuticals, Inc. ICPT | BlackRock Inc. BLK | 4,396,970 10.500% | 1,312,137 (+42.54%) | Filing |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT | BlackRock Inc. BLK | 3,084,833 7.400% | 852,741 (+38.20%) | Filing |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT | BlackRock Inc. BLK | 2,232,092 7.600% | -266,316 (-10.66%) | Filing |
| 2021-01-29 09:56 am Purchase | 2020-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT | BlackRock Inc. BLK | 2,498,408 7.600% | 183,940 (+7.95%) | Filing |